SGMO

#3170
Sangamo Therapeutics, Inc. Common Stock
0.43
-4.44%
Setor:
Base:
Moeda do lucro:
Faixa diária
0.43
0.43
Faixa anual
0.35
1.07
Mudança diária
-4.44%
Mudança mensal
+13.16%
Mudança em 6 meses
-20.37%
Mudança anual
-56.12%
Fechamento anterior
0.45
Open
0.43
Bid
Ask
Low
0.43
High
0.43
Volume
17
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

Notícias